Revenue,
USD USD 83.87 Bn
Forecast Year,
USD USD 193.16 Bn
CAGR, 2025 -
8.7%
Report Coverage
Worldwide
Non-Oncology Precision Medicine Market Size Analysis
Non-Oncology Precision Medicine Market Size By Product Type 2024 to 2034 (USD )
| Product Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics | 46.13 | 50.05 | 54.31 | 58.92 | 63.93 | 69.37 | 75.26 | 81.66 | 88.60 | 96.13 | 104.30 |
| Therapeutics | 37.74 | 41.12 | 44.79 | 48.80 | 53.16 | 57.91 | 63.09 | 68.73 | 74.87 | 81.56 | 88.85 |
Non-Oncology Precision Medicine Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CNS | 15.10 | 16.46 | 17.94 | 19.55 | 21.31 | 23.23 | 25.32 | 27.60 | 30.08 | 32.78 | 35.73 |
| Oncology | 10.06 | 10.97 | 11.95 | 13.02 | 14.19 | 15.46 | 16.85 | 18.36 | 20.01 | 21.80 | 23.76 |
| Immunology | 12.58 | 13.69 | 14.90 | 16.22 | 17.66 | 19.22 | 20.92 | 22.77 | 24.78 | 26.97 | 29.36 |
| Respiratory | 11.74 | 12.79 | 13.93 | 15.18 | 16.53 | 18.01 | 19.62 | 21.37 | 23.28 | 25.36 | 27.62 |
| Infectious Diseases | 10.90 | 11.82 | 12.82 | 13.91 | 15.08 | 16.36 | 17.74 | 19.23 | 20.86 | 22.62 | 24.53 |
| Neurology | 8.39 | 9.13 | 9.95 | 10.84 | 11.80 | 12.86 | 14.00 | 15.25 | 16.61 | 18.09 | 19.70 |
| Others | 15.10 | 16.30 | 17.60 | 19.00 | 20.51 | 22.15 | 23.91 | 25.81 | 27.86 | 30.07 | 32.45 |
Non-Oncology Precision Medicine Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 41.94 | 45.54 | 49.45 | 53.70 | 58.31 | 63.32 | 68.76 | 74.67 | 81.08 | 88.05 | 95.61 |
| Diagnostic Centers | 16.77 | 18.25 | 19.86 | 21.61 | 23.51 | 25.58 | 27.84 | 30.29 | 32.96 | 35.86 | 39.02 |
| Research & Academic Institutes | 16.77 | 18.26 | 19.88 | 21.64 | 23.56 | 25.65 | 27.92 | 30.39 | 33.09 | 36.02 | 39.21 |
| Others | 8.39 | 9.12 | 9.91 | 10.77 | 11.71 | 12.73 | 13.84 | 15.04 | 16.35 | 17.77 | 19.32 |
Non-Oncology Precision Medicine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 33.55 | 36.38 | 39.44 | 42.76 | 46.37 | 50.27 | 54.51 | 59.10 | 64.08 | 69.48 | 75.33 |
| Europe | 20.97 | 22.75 | 24.68 | 26.77 | 29.04 | 31.50 | 34.17 | 37.07 | 40.21 | 43.62 | 47.32 |
| Asia-Pacific | 16.77 | 18.32 | 20.02 | 21.87 | 23.89 | 26.09 | 28.50 | 31.13 | 34.00 | 37.14 | 40.56 |
| Latin America | 6.71 | 7.31 | 7.97 | 8.68 | 9.46 | 10.31 | 11.23 | 12.24 | 13.34 | 14.54 | 15.84 |
| Middle East & Africa | 5.87 | 6.41 | 7.00 | 7.64 | 8.34 | 9.10 | 9.93 | 10.84 | 11.84 | 12.92 | 14.10 |
Non-Oncology Precision Medicine Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com